Investor Stock List
Ranked #2,361 of 8,699 institutional investors

SR One Capital Management, LP

Redwood City, CA

$996M
US stock portfolio at live prices · today −$6.5M (−0.65%)
Live prices, last trade 9:49 AM ET
Value at quarter end (Q3 2026)
$1.15B
Change from Q2 2026
+$110.5M (+10.64%)
Positions
15 · 3 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$119M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
MANE 25.5%ADRX 14.1%ZBIO 12.7%AVLN 9.59%ODTX 6.61%
StockSharesValue, live% of portfoliovs Q2 2026
MANE Veradermics Inc2,080,119$253M25.5%Reduced −13%
ADRX ADARx Pharmaceuticals, Inc.9,936,661$140M14.1%New
ZBIO Zenas BioPharma, Inc.5,037,854$127M12.7%Unchanged
AVLN Avalyn Pharma Inc.3,308,649$95.5M9.59%Unchanged
ODTX Odyssey Therapeutics, Inc.3,794,883$65.8M6.61%Unchanged
DSGN Design Therapeutics, Inc.6,526,476$61.3M6.16%Unchanged
ORIC ORIC Pharmaceuticals, Inc.4,615,384$36.3M3.65%Unchanged
KRSA Korsana Biosciences, Inc.613,915$23.2M2.33%New
MOBI Mobia Medical, Inc.1,986,072$23.1M2.32%Unchanged
MLYS Mineralys Therapeutics, Inc.1,563,966$22.0M2.21%Unchanged
SPRY ARS Pharmaceuticals, Inc.4,012,903$13.5M1.36%Unchanged
ALMS Alumis Inc.1,959,896$8.4M0.84%Unchanged
NKTX Nkarta, Inc.3,333,333$3.9M0.39%Unchanged
RARE Ultragenyx Pharmaceutical Inc.137,753$2.4M0.24%Unchanged
ENGN enGene Therapeutics Inc.747,750$1.3M0.13%New